Physician profile
Ryan Heitmann
NPI 1861663056
$1,391.58
in general payments reported to CMS, 2019-2025
14 companies · $20.91 in 2025
The $20.91 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.32 · 2022: $159 · 2023: $652 · 2024: $479 · 2025: $20.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $349.44 | 2023-2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $130.01 | 2023-2025 | Enseal X1, Harmonic, Vistaseal |
| Boston Scientific Corporation | $124.15 | 2024 | Solyx Sis System |
| Organon LLC | $114.99 | 2024 | |
| Coopersurgical, INC. | $114.75 | 2021-2024 | Sos |
| Astellas Pharma US INC | $99.99 | 2023 | |
| Intuitive Surgical, INC. | $89.11 | 2022 | |
| Axonics, INC. | $85.35 | 2024 | Bulkamid |
| Smith+Nephew, INC. | $84.91 | 2023 | Pico 7 |
| Servier Pharmaceuticals LLC | $76.01 | 2023 | |
| Conmed Corporation | $53.57 | 2022 | |
| Ferring Pharmaceuticals INC. | $53.21 | 2021-2022 | |
| Hologic Sales and Service, LLC | $16.09 | 2024 | Myosure Tissue Removal Device, Novasure |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Heitmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.